The iCAN flagship is a new innovative cancer research platform formed by the University of Helsinki, Helsinki Universty Hospital and a number of new partners. iCAN integrates precision cancer medicine and digital health/lifestyle data, thereby enabling development of personalized cancer treatments and new health sector innovations.